| 2026 |
| 06/03 | 290 | 290 | 281 | 286 | -2.05% | 78,800 | 179億2682万 | -3.38% |
| 06/02 | 287 | 295 | 280 | 292 | +2.1% | 161,000 | 183億291万 | -1.68% |
| 06/01 | 296 | 297 | 285 | 286 | -3.38% | 128,800 | 179億2682万 | -4.03% |
| 06/01 | （空売り報告）GOLDMAN SACHS INTERNATIONAL 372,857株（0.59%）-0.01% |
| 05/29 | 292 | 300 | 292 | 296 | +1.72% | 109,200 | 185億5363万 | -1% |
| 05/29 | （空売り報告）GOLDMAN SACHS INTERNATIONAL 379,457株（0.6%）+0.1% |
| 05/28 | 294 | 299 | 289 | 291 | -1.36% | 135,700 | 182億4022万 | -3% |
| 05/27 | 288 | 298 | 286 | 295 | +2.43% | 135,400 | 184億9095万 | -1.99% |
| 05/26 | 288 | 294 | 286 | 288 | -0.35% | 106,100 | 180億5218万 | -4.64% |
| 05/25 | 293 | 293 | 279 | 289 | -1.37% | 211,700 | 181億1486万 | -4.62% |
| 05/22 | 286 | 293 | 286 | 293 | +2.45% | 137,900 | 183億6559万 | -3.62% |
| 05/21 | 286 | 291 | 286 | 286 | +0.35% | 116,800 | 179億2682万 | -5.92% |
| 05/20 | 294 | 296 | 283 | 285 | -3.39% | 310,800 | 178億6414万 | -6.56% |
| 05/19 | 291 | 298 | 289 | 295 | +1.72% | 144,400 | 184億9095万 | -3.59% |
| 05/18 | 306 | 306 | 288 | 290 | -5.54% | 423,800 | 181億7754万 | -5.54% |
| 05/18 | （空売り報告）GOLDMAN SACHS INTERNATIONAL 315,357株（0.5%）再IN |
| 05/15 | 311 | 313 | 303 | 307 | -0.97% | 255,400 | 192億4312万 | -0.32% |
| 05/14 | （IR情報）17:45 再生誘導医薬レダセムチド（HMGB1ペプチド）における慢性肝疾患を対象とした第2相医師主導治験に関する論文掲載のお知らせ |
| 05/14 | 308 | 323 | 308 | 310 | +0.98% | 271,400 | 194億3117万 | +0.65% |
| 05/13 | （IR情報）15:30 臨時株主総会招集のための基準日設定及び臨時株主総会の開催並びに資本金の額の減少(減資)に関するお知らせ |
| 05/13 | 311 | 318 | 302 | 307 | +1.32% | 251,700 | 192億4312万 | 0% |
| 05/12 | （IR情報）16:15 再生誘導医薬レダセムチドに関する進捗状況のお知らせ |
| 05/12 | 304 | 308 | 302 | 303 | 0% | 89,800 | 189億9240万 | -1.3% |
| 05/11 | 302 | 305 | 299 | 303 | +1% | 117,000 | 189億9240万 | -1.62% |
| 05/08 | 295 | 303 | 291 | 300 | +1.35% | 137,900 | 188億436万 | -2.28% |
| 05/07 | 302 | 302 | 292 | 296 | -1% | 157,300 | 185億5363万 | -3.58% |
| 05/01 | 300 | 300 | 295 | 299 | -0.33% | 37,900 | 187億4167万 | -2.61% |
| 04/30 | 302 | 302 | 296 | 300 | -0.33% | 77,900 | 188億436万 | -2.28% |
| 04/28 | 300 | 304 | 298 | 301 | +0.33% | 76,900 | 188億6704万 | -1.95% |
| 04/27 | 303 | 303 | 298 | 300 | -0.99% | 87,100 | 188億436万 | -1.96% |
| 04/24 | 305 | 307 | 300 | 303 | -1.94% | 139,500 | 189億9240万 | -0.98% |
| 04/23 | 312 | 312 | 305 | 309 | -1.28% | 112,100 | 193億6849万 | +1.31% |
| 04/22 | 318 | 318 | 310 | 313 | -1.57% | 78,800 | 196億1921万 | +2.62% |
| 04/21 | 319 | 320 | 312 | 318 | +0.63% | 77,700 | 199億3262万 | +4.26% |
| 04/20 | 308 | 321 | 308 | 316 | +1.61% | 111,600 | 198億725万 | +3.95% |
| 04/17 | 316 | 320 | 308 | 311 | -2.51% | 119,800 | 194億9385万 | +2.64% |
| 04/16 | 318 | 326 | 316 | 319 | +0.63% | 201,000 | 199億9530万 | +5.28% |
| 04/15 | （IR情報）15:30 再生誘導医薬レダセムチド(HMGB1ペプチド)における虚血性心筋症患者を対象とした第1⁄2相医師主導治験の患者組み入れ完了のお知らせ |
| 04/15 | 313 | 320 | 312 | 317 | +1.6% | 207,300 | 198億6994万 | +4.97% |
| 04/14 | 308 | 313 | 306 | 312 | +1.3% | 80,600 | 195億5653万 | +3.31% |
| 04/13 | 302 | 308 | 298 | 308 | +1.32% | 132,500 | 193億580万 | +2.33% |
| 04/10 | 310 | 313 | 301 | 304 | -0.98% | 92,700 | 190億5508万 | +1% |
| 04/09 | 325 | 325 | 305 | 307 | -5.25% | 184,600 | 192億4312万 | +2.33% |
| 04/08 | 315 | 325 | 313 | 324 | +3.85% | 337,000 | 203億870万 | +8.36% |
| 04/08 | （空売り報告）モルガン・スタンレーMUFG証券 312,814株（0.49%）-0.06%義務消失 |
| 04/07 | 304 | 314 | 303 | 312 | +2.97% | 148,600 | 195億5653万 | +4.7% |
| 04/06 | 300 | 306 | 300 | 303 | +1.34% | 28,600 | 189億9240万 | +2.02% |
| 04/03 | 307 | 309 | 298 | 299 | -2.61% | 88,900 | 187億4167万 | +0.67% |
| 04/02 | 305 | 315 | 303 | 307 | 0% | 212,800 | 192億4312万 | +3.37% |
| 04/01 | 299 | 308 | 295 | 307 | +4.78% | 126,500 | 192億4312万 | +3.37% |
| 03/31 | 291 | 304 | 288 | 293 | +1.38% | 106,700 | 183億6559万 | -1.01% |
| 03/30 | 291 | 296 | 287 | 289 | -4.62% | 119,100 | 181億1486万 | -2.36% |
| 03/27 | 288 | 307 | 284 | 303 | +4.12% | 195,100 | 189億9240万 | +2.02% |
| 03/26 | 301 | 304 | 288 | 291 | -3.32% | 123,200 | 182億4022万 | -2.02% |
| 03/25 | 296 | 312 | 296 | 301 | +1.69% | 260,200 | 188億6704万 | +1.01% |
| 03/24 | 288 | 297 | 282 | 296 | +5.71% | 441,500 | 185億5363万 | -0.67% |
| 03/23 | 289 | 291 | 280 | 280 | -5.41% | 220,000 | 175億5073万 | -6.04% |
| 03/19 | 298 | 301 | 295 | 296 | -2.31% | 74,400 | 185億5363万 | -0.67% |
| 03/18 | 304 | 306 | 300 | 303 | -0.33% | 63,900 | 189億9240万 | +1.68% |
| 03/17 | 305 | 315 | 300 | 304 | -0.33% | 246,100 | 190億5508万 | +2.36% |
| 03/16 | 295 | 308 | 295 | 305 | +3.04% | 200,100 | 191億1776万 | +2.69% |
| 03/13 | （IR情報）16:00 2026年7月期半期決算説明資料 |
| 03/13 | 291 | 300 | 291 | 296 | -1% | 149,300 | 185億5363万 | 0% |
| 03/12 | 300 | 306 | 297 | 299 | -1.64% | 203,600 | 187億4167万 | +1.01% |
| 03/11 | （IR情報）15:30 2026年7月期第2四半期決算短信〔日本基準〕(非連結) |
| 03/11 | 300 | 307 | 300 | 304 | +1.33% | 237,800 | 190億5508万 | +3.05% |
| 03/10 | 292 | 302 | 291 | 300 | +3.45% | 151,400 | 188億436万 | +2.04% |
| 03/09 | 285 | 293 | 282 | 290 | -3.33% | 155,300 | 181億7754万 | -1.36% |
| 03/06 | 298 | 300 | 293 | 300 | +1.01% | 107,000 | 188億436万 | +2.04% |
| 03/05 | 284 | 298 | 284 | 297 | +6.83% | 149,400 | 186億1631万 | +0.68% |
| 03/04 | 288 | 292 | 275 | 278 | -6.08% | 367,000 | 174億2537万 | -5.76% |
| 03/04 | （空売り報告）GOLDMAN SACHS INTERNATIONAL 298,257株（0.47%）-0.08%義務消失 |
| 03/03 | 303 | 305 | 293 | 296 | +0.34% | 426,400 | 185億5363万 | 0% |
| 03/03 | （空売り報告）モルガン・スタンレーMUFG証券 344,914株（0.55%）再IN |
| 03/02 | （IR情報）15:30 栄養障害型表皮水疱症の根治治療を目的とした幹細胞遺伝子治療技術(開発コード:SR-GT1)の特許登録(日本)のお知らせ |
| 03/02 | 299 | 308 | 285 | 295 | -3.91% | 498,400 | 184億9095万 | 0% |
| 02/27 | 296 | 307 | 296 | 307 | +3.02% | 243,600 | 192億4312万 | +4.07% |
| 02/26 | 291 | 307 | 287 | 298 | +1.36% | 323,900 | 186億7899万 | +1.36% |
| 02/25 | 292 | 301 | 287 | 294 | +1.03% | 158,000 | 184億2827万 | 0% |
| 02/24 | 295 | 297 | 288 | 291 | -2.68% | 152,500 | 182億4022万 | -1.02% |
| 02/20 | 306 | 309 | 296 | 299 | -2.29% | 213,500 | 187億4167万 | +1.7% |
| 02/19 | 304 | 307 | 295 | 306 | -0.33% | 265,500 | 191億8044万 | +4.08% |
| 02/18 | 311 | 314 | 301 | 307 | +0.66% | 703,600 | 192億4312万 | +4.78% |
| 02/17 | （IR情報）15:30 再生誘導医薬レダセムチド(HMGB1断片ペプチド)の軟骨疾患を適応症とした特許登録(カナダ)のお知らせ |
| 02/17 | 294 | 309 | 292 | 305 | +2.69% | 215,900 | 191億1776万 | +4.81% |
| 02/16 | 290 | 297 | 285 | 297 | +2.06% | 90,600 | 186億1631万 | +2.41% |
| 02/13 | 298 | 298 | 288 | 291 | -1.69% | 60,600 | 182億4022万 | +0.34% |
| 02/12 | （IR情報）14:00 「バイオIR Day」への登壇に関するお知らせ |
| 02/12 | 292 | 301 | 290 | 296 | +1.37% | 93,100 | 185億5363万 | +2.42% |
| 02/10 | 285 | 296 | 285 | 292 | +2.1% | 109,500 | 183億291万 | +1.39% |
| 02/09 | 293 | 294 | 286 | 286 | +0.35% | 90,100 | 179億2682万 | -0.35% |
| 02/06 | 289 | 290 | 278 | 285 | -3.72% | 185,500 | 178億6414万 | -0.35% |
| 02/05 | 280 | 296 | 280 | 296 | +5.34% | 126,400 | 185億5363万 | +3.86% |
| 02/05 | （空売り報告）GOLDMAN SACHS INTERNATIONAL 346,257株（0.55%）-0.07% |
| 02/04 | 282 | 284 | 279 | 281 | -1.06% | 63,100 | 176億1341万 | -0.71% |
| 02/04 | （空売り報告）GOLDMAN SACHS INTERNATIONAL 389,257株（0.62%）+0.04% |
| 02/03 | 286 | 289 | 282 | 284 | -0.7% | 86,200 | 178億146万 | +0.71% |
| 02/02 | 287 | 290 | 285 | 286 | -1.38% | 75,700 | 179億2682万 | +1.78% |
| 01/30 | 297 | 298 | 285 | 290 | -1.69% | 165,800 | 181億7754万 | +3.2% |
| 01/29 | 309 | 309 | 294 | 295 | -5.14% | 181,900 | 184億9095万 | +5.73% |
| 01/28 | 297 | 314 | 295 | 311 | +4.71% | 297,100 | 194億9385万 | +11.87% |
| 01/27 | 310 | 310 | 297 | 297 | -1.98% | 134,100 | 186億1631万 | +8% |
| 01/26 | 298 | 308 | 292 | 303 | +4.12% | 191,900 | 189億9240万 | +10.99% |
| 01/23 | 290 | 295 | 286 | 291 | +2.11% | 51,900 | 182億4022万 | +7.38% |
| 01/22 | 291 | 291 | 285 | 285 | -1.04% | 54,000 | 178億6414万 | +5.56% |
| 01/21 | 288 | 289 | 285 | 288 | -1.71% | 67,700 | 180億5218万 | +7.06% |
| 01/20 | 304 | 304 | 292 | 293 | -3.93% | 205,800 | 183億6559万 | +9.33% |
| 01/19 | 295 | 306 | 293 | 305 | +5.17% | 199,200 | 191億1776万 | +14.66% |
| 01/16 | 290 | 296 | 287 | 290 | +0.35% | 99,900 | 181億7754万 | +9.43% |
| 01/15 | 277 | 291 | 275 | 289 | +5.86% | 199,300 | 181億1486万 | +9.89% |
| 01/15 | （空売り報告）GOLDMAN SACHS INTERNATIONAL 369,257株（0.58%）-0.03% |
| 01/14 | 274 | 278 | 272 | 273 | -1.09% | 91,000 | 171億1196万 | +4.2% |
| 01/14 | （空売り報告）GOLDMAN SACHS INTERNATIONAL 384,757株（0.61%）+0.09% |
| 01/13 | 279 | 282 | 272 | 276 | -1.08% | 154,200 | 173億1万 | +5.75% |
| 01/09 | 283 | 288 | 275 | 279 | -0.71% | 139,200 | 174億8805万 | +7.31% |
| 01/08 | 274 | 286 | 274 | 281 | +2.55% | 198,100 | 176億1341万 | +8.08% |
| 01/07 | 270 | 276 | 266 | 274 | +1.48% | 114,500 | 171億7464万 | +5.79% |
| 01/07 | （空売り報告）モルガン・スタンレーMUFG証券 297,914株（0.47%）-0.03%義務消失 |
| 01/06 | 265 | 274 | 264 | 270 | +1.89% | 127,500 | 169億2392万 | +3.85% |
| 01/05 | 264 | 265 | 260 | 265 | +0.76% | 119,700 | 166億1051万 | +1.92% |
| 01/05 | （空売り報告）モルガン・スタンレーMUFG証券 315,314株（0.5%）再IN |
10年以上蓄積したファイナンスデータとAIを掛け合わせて、投資の意思決定を加速させるポジションです。
